240 related articles for article (PubMed ID: 24484467)
1. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
Coulibaly SO; Kayentao K; Taylor S; Guirou EA; Khairallah C; Guindo N; Djimde M; Bationo R; Soulama A; Dabira E; Barry B; Niangaly M; Diakite H; Konate S; Keita M; Traore B; Meshnick SR; Magnussen P; Doumbo OK; ter Kuile FO
Malar J; 2014 Jan; 13():41. PubMed ID: 24484467
[TBL] [Abstract][Full Text] [Related]
2. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
[TBL] [Abstract][Full Text] [Related]
3. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
[TBL] [Abstract][Full Text] [Related]
4. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
[TBL] [Abstract][Full Text] [Related]
5. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
[TBL] [Abstract][Full Text] [Related]
6. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
COSMIC Consortium
Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
[TBL] [Abstract][Full Text] [Related]
7. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
Tan KR; Katalenich BL; Mace KE; Nambozi M; Taylor SM; Meshnick SR; Wiegand RE; Chalwe V; Filler SJ; Kamuliwo M; Craig AS
Malar J; 2014 Jun; 13():227. PubMed ID: 24909578
[TBL] [Abstract][Full Text] [Related]
9. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.
Gutman J; Mwandama D; Wiegand RE; Abdallah J; Iriemenam NC; Shi YP; Mathanga DP; Skarbinski J
Malar J; 2015 May; 14():197. PubMed ID: 25962439
[TBL] [Abstract][Full Text] [Related]
12. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
[TBL] [Abstract][Full Text] [Related]
13. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
Walker PG; Floyd J; Ter Kuile F; Cairns M
PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
[TBL] [Abstract][Full Text] [Related]
14. Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Traoré-Coulibaly M; Tinto H; Schallig HDFH; Mens PF
Mol Biochem Parasitol; 2017 Oct; 217():13-15. PubMed ID: 28818675
[TBL] [Abstract][Full Text] [Related]
15. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
[TBL] [Abstract][Full Text] [Related]
16. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.
Gies S; Coulibaly SO; Ky C; Ouattara FT; Brabin BJ; D'Alessandro U
Am J Trop Med Hyg; 2009 Mar; 80(3):460-9. PubMed ID: 19270299
[TBL] [Abstract][Full Text] [Related]
17. Determinants of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey.
Sangho O; Tounkara M; Whiting-Collins LJ; Beebe M; Winch PJ; Doumbia S
Malar J; 2021 May; 20(1):231. PubMed ID: 34022901
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
[TBL] [Abstract][Full Text] [Related]
19. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Yaro JB; Ouedraogo A; Diarra A; Sombié S; Ouedraogo ZA; Nébié I; Drakeley C; Sirima SB; Tiono AB; Lindsay SW; Wilson AL
Malar J; 2021 Sep; 20(1):362. PubMed ID: 34488770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
